While trends toward higher CDI and non-clostridial infection risks were observed, these did not reach statistical significance ( Table 4 and Table 5 ), potentially due to small subgroup sample sizes or unadjusted confounders.
← all excerpts
Impact of Biologics and Proton Pump Inhibitors on Gastrointestinal Infection Risk in Inflammatory Bowel Disease Patients: A Retrospective Analysis of Pathogen-Specific Outcomes and Treatment Interactions.
1
—
—